Angioplasty.Org
Most Popular Angioplasty Web Site
    
supported by Volcano Corporation
Volcano Corporation Presentation at Canaccord Genuity Conference to be Webcast
Share This Story:
Email
Bookmark and Share

related stories:
Intravascular
Imaging Center

All Volcano Press Releases

external sites:
Volcano Corporation
August 2, 2011 -- San Diego -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral vascular disease, said today that it will be participating in the 2011 Canaccord Genuity Growth Conference on Tuesday, August 9.

Scott Huennekens, president and CEO
Scott Huennekens		    

The presentation by Scott Huennekens, president and chief executive officer, will begin at 11 a.m., Eastern Daylight Time (8 a.m., Pacific Daylight Time).

The presentation will be available through the conference website at http://www.wsw.com/webcast/canaccord4/volc/ and via the company's website at www.volcanocorp.com.

Volcano Corporation is revolutionizing the medical device industry with a broad suite of technologies that make imaging and therapy simpler, more informative and less invasive. Our products empower physicians around the world with a new generation of analytical tools that deliver more meaningful information—using light and sound as the guiding elements. Founded in cardiovascular care and expanding into other specialties, Volcano is changing the assumption about what is possible in improving patient outcomes by combining imaging and therapy together. For more information, visit the company's website at www.volcanocorp.com.

Source: Volcano Corporation

send comments & suggestions to "info at angioplasty dot org"
Read our Privacy statement.

Angioplasty.Org is an editorially independent informational health site
which has received unrestricted educational grants from
Medtronic plc, TCROSS NEWS, Toshiba America Medical Systems, Volcano Corporation, Terumo Medical Corporation
Cardium Therapeutics, Inc. and Lenox Hill Heart and Vascular Institute of NY

For more information, see About Us
All content, including text, photos and video
© Copyright Venture Digital LLC 1996-2022